Oncologix Inc. deal

Oncologix Inc. Oncologix acquired exclusive worldwide rights to Merck & Co. Inc.'s TP40 oncotoxin. The Gaithersburg, Md., company plans to develop the drug, renamed OLX-103, to treat tumors that ove...